CROSS-STANDARD public interest · Cosmetics & personal care

China-to-UK Cosmetics Compliance Gap Matrix

AI-compiled from official public sources — cross-checked by multiple AI models, not human-verified. Informational only; see disclaimer. Public-interest, source-linked comparison of common China cosmetic product documentation against UK Cosmetics Regulation requirements: UK Responsible Person, SCPN notification, Cosmetic Product Safety Report, prohibited and restricted substance schedules, GMP (ISO 22716), and labelling (INCI, claims).

Dataset 2026-06-11 Last verified 2026-06-12 5 rows

GAP MATRIX

Compliance Gap Matrix

Gap matrix
Compliance item Common China baseline United Kingdom (UK Cosmetics Regulation) Gap / action Source + verification date
Cosmetic Product Safety Report (CPSR) China requires a quality and safety control file (product quality and safety related materials) as part of the NMPA registration or filing dossier. For imported special-use cosmetics, the dossier includes safety assessment data, formulation, manufacturing process, and clinical/efficacy evidence. The 'safety assessment' under China's Technical Guidelines for Safety Assessment of Cosmetics (2021) has a similar purpose to the CPSR Part B but uses different risk criteria and exposure models. NMPA-approved dossiers are not accepted as CPSR substitutes in the UK.化妆品监督管理条例 (CSAR 2021), Articles 17–22
化妆品安全评估技术导则 (2021) — Technical Guidelines for Safety Assessment of Cosmetics (NMPA)
化妆品注册备案资料管理规定 (2021) — Provisions on Management of Registration and Filing Dossiers		 Before a cosmetic product is placed on the GB market, the UK Responsible Person must ensure that a Cosmetic Product Safety Report (CPSR) has been prepared. The CPSR must be kept at the UK RP's address and made available to enforcement authorities on request. Under the retained Regulation (EC) 1223/2009 (UK law), the CPSR consists of two mandatory parts: Part A (Cosmetic Product Safety Information — formulation, physicochemical/microbiological specifications, impurities, packaging, use and exposure, toxicological profile, undesirable effects, information on the cosmetic product) and Part B (Cosmetic Product Safety Assessment — assessment conclusion, labelled warnings/instructions, reasoning, assessor credentials). The safety assessment must be performed by a person qualified in pharmacy, toxicology, medicine, or similar discipline (the 'qualified assessor'). The CPSR must be updated if a safety-relevant change is made to the formulation.Retained Regulation (EC) No 1223/2009, Article 10 and Annex I (as retained in UK law)
The Cosmetic Products Enforcement Regulations 2013 (SI 2013/1478, as amended)
OPSS guidance: Cosmetic Product Safety Reports (GOV.UK)		 A CPSR prepared by a UK/EU-qualified assessor (pharmacy, toxicology, medicine or equivalent) is required for every product placed on the GB market. Chinese NMPA safety dossiers do not substitute. The CPSR must comply with the Annex I structure (Parts A and B) under the retained UK regulation. In practice, exporters typically commission a UK or EU toxicologist to prepare or validate the CPSR using the Chinese formulation data as input. Key gaps: (1) assessor must meet UK qualification requirements; (2) UK-specific exposure assumptions and SCCS scientific opinions may differ from Chinese guidelines; (3) CPSR must be held at the UK RP's address, not in China.[INFORMATIONAL] A CPSR conforming to retained Regulation 1223/2009 Annex I is mandatory for every cosmetic product on the GB market. Chinese NMPA safety files do not satisfy this requirement. Exporters must commission a UK/EU-qualified toxicologist or safety assessor to prepare Part B; Part A can draw on existing Chinese formulation documentation but must be structured per Annex I. The CPSR must be held at the UK RP's address. legislation.gov.uk (retained EU Regulation 1223/2009, Annex I)2026-06-12 · unverified
Good Manufacturing Practice (GMP) — ISO 22716 China requires cosmetic manufacturers to comply with the Cosmetics Production Quality Management Standards (commonly called 'Cosmetics GMP'), effective from 2022, published by NMPA. This standard is aligned in principle with ISO 22716 but is a mandatory Chinese regulatory instrument — facilities must pass a GMP inspection by provincial market supervision authorities before receiving a cosmetics production licence. Third-party certification to ISO 22716 is not a substitute for the Chinese GMP licence. Chinese manufacturers with a valid cosmetics production licence have passed domestic GMP inspections, but UK/EU authorities do not accept the Chinese GMP licence as evidence of ISO 22716 compliance.化妆品生产质量管理规范 (2022) — Cosmetics Production Quality Management Standards (NMPA)
化妆品生产许可管理办法 (2021) — Measures for Administration of Cosmetics Production Licence		 The retained Regulation (EC) 1223/2009 (UK law) requires cosmetic products to be manufactured in compliance with Good Manufacturing Practice (GMP). That regulation is the mandatory legal obligation. ISO 22716:2007 / EN ISO 22716:2007 is a voluntary harmonised/designated standard route that can support a presumption of conformity with the GMP requirement when correctly applied; it is not itself mandatory law, a sole accepted method, or a required third-party certification. The UK RP does not need a third-party ISO 22716 certificate, but must be able to demonstrate that the manufacturing site operates according to GMP principles (personnel, premises, equipment, raw materials, production, finished products, quality control, outsourced activities, deviations, complaints, recalls). Enforcement (OPSS and Trading Standards) may request manufacturing documentation.Retained Regulation (EC) No 1223/2009, Article 8 (GMP requirement) (as retained in UK law)
ISO 22716:2007 — Cosmetics — Good Manufacturing Practices (GMP) — Guidelines on Good Manufacturing Practices
EN ISO 22716:2007 (European adoption of ISO 22716)		 The Chinese cosmetics GMP licence demonstrates domestic regulatory compliance but does not automatically establish conformity with the UK GMP obligation. The UK RP may use ISO 22716 / EN ISO 22716 evidence as a voluntary presumption-of-conformity route, but alternatives are allowed if the RP can show the retained UK regulation's GMP requirement is met. In practice, UK RPs rely on: (1) self-declaration by the manufacturer that the facility operates per ISO 22716 or an equivalent documented GMP system; (2) audit reports from the UK RP or third-party auditors; (3) Chinese ISO 22716 certificates issued by accredited certification bodies (voluntary in China but useful evidence). If the manufacturing facility has a Chinese cosmetics production licence, this provides a baseline, but the UK RP should verify scope, documentation, and any deviations from ISO 22716 chapter coverage or equivalent GMP controls.[INFORMATIONAL] The mandatory UK obligation is the retained Cosmetics Regulation requirement to manufacture in accordance with GMP. ISO 22716 / EN ISO 22716 is voluntary and can support a presumption of conformity, but it is not mandatory law and is not the sole accepted route. Third-party certification is not required, but the UK RP must be able to demonstrate GMP conformity. Chinese cosmetics production licences do not substitute automatically; a voluntary ISO 22716 certificate or equivalent audit evidence can help evidence UK GMP compliance. legislation.gov.uk (retained Regulation (EC) 1223/2009, Article 8)2026-06-12 · unverified
Labelling — INCI Ingredients, Mandatory Information & Claims (UK) China's labelling requirements for cosmetics are set out in GB 5296.3-2008 (Instructions for use of consumer products — Part 3: Cosmetics) and the CSAR 2021/implementing rules. Mandatory elements include: product name, name and address of the responsible entity in China, net content, date of manufacture and shelf life (or PAO), ingredient list (in descending order by weight, using INCI names or Chinese INCI equivalents), usage instructions, warnings, and licence/registration number. Chinese labels must be in simplified Chinese. An INCI ingredient list is required, but the Chinese INCI nomenclature database is used rather than the international INCI list — some ingredient name translations may differ.GB 5296.3-2008 — Instructions for use of consumer products — Part 3: Cosmetics
化妆品监督管理条例 (CSAR 2021) — labelling provisions
化妆品标签管理办法 (2021) — Measures for the Administration of Cosmetic Labels (NMPA)		 Cosmetics placed on the GB market must carry labelling complying with retained Regulation (EC) 1223/2009 (UK law), Article 19. Mandatory label elements include: (1) Name and address of the UK Responsible Person; (2) Country of origin (for products manufactured outside the UK); (3) Nominal content by mass or volume; (4) Date of minimum durability ('best before' or 'use by', if shelf life 30 months or less) or Period After Opening (PAO) symbol if shelf life exceeds 30 months; (5) Precautions for use and warnings (including those required by the Schedules); (6) Batch number or reference; (7) Function of the product; (8) List of ingredients in descending order of weight (INCI nomenclature), prefixed 'Ingredients:'. All mandatory information must be in English (and may include other languages). Labels must be indelible, legible, and visible. Claims (e.g., 'hypoallergenic', 'dermatologically tested', 'natural') are subject to the UK Common Criteria for cosmetic product claims (retained Regulation (EU) 655/2013 in UK law), which requires claims to be truthful, evidenced, and not misleading.Retained Regulation (EC) No 1223/2009, Article 19 (labelling requirements) (as retained in UK law)
Retained Regulation (EU) No 655/2013 (common criteria for cosmetic product claims) (as retained in UK law)
GB 5296.3 (China labelling standard — for reference/comparison only)
INCI nomenclature (International Nomenclature of Cosmetic Ingredients — maintained by the Personal Care Products Council)		 Chinese labels (GB 5296.3 / CSAR 2021) are in simplified Chinese and reference the China RP, China licence number, and Chinese INCI names — none of these satisfy the UK label requirements. Key gaps: (1) Labels must be in English and must show the UK RP's name/address (not the Chinese manufacturer or China RP); (2) INCI ingredient names must use the international INCI nomenclature (not Chinese INCI translations — verify name equivalences); (3) UK-specific warnings required by the Schedules must appear (may differ from Chinese regulatory warnings); (4) Batch code format must allow traceability to the UK RP's records; (5) Claims must comply with UK Common Criteria — Chinese claims evidence (e.g., NMPA-approved efficacy claims) is not automatically valid under UK law. New packaging with English labels is required for UK market entry.[INFORMATIONAL] UK labelling under retained Regulation 1223/2009 Article 19 is mandatory and materially different from Chinese GB 5296.3 requirements. New English-language labels identifying the UK RP are required for every product entering the GB market. INCI names, UK-schedule warnings, and claim substantiation under UK Common Criteria must all be verified. Chinese label content cannot be reused without legal review and reformatting. legislation.gov.uk (retained Regulation (EC) 1223/2009, Article 19)2026-06-12 · unverified
UK Responsible Person & SCPN Notification China requires cosmetic products to be registered or filed with the National Medical Products Administration (NMPA) before market entry. Special-use cosmetics (e.g., hair dyes, sunscreens, anti-ageing claims, whitening) require full NMPA registration (approx. 6–18 months); ordinary cosmetics require NMPA filing (备案). Imported cosmetics must be registered/filed by a China-established responsible agent. The NMPA system (化妆品注册备案管理系统) is the Chinese equivalent notification platform. Regulatory basis: Cosmetic Supervision and Administration Regulation (CSAR, 化妆品监督管理条例, 2021) and its implementing rules.化妆品监督管理条例 (CSAR 2021) — Cosmetic Supervision and Administration Regulation
化妆品注册备案管理办法 (2021) — Measures for Administration of Registration and Filing of Cosmetics
NMPA cosmetics registration/filing system (国家药监局化妆品注册备案管理系统)		 Every cosmetic product placed on the Great Britain (England, Scotland, Wales) market must have a designated UK Responsible Person (RP) — either the manufacturer (if UK-established) or an importer/authorised representative established in Great Britain. The RP is legally responsible for ensuring the product complies with The Cosmetic Products Enforcement Regulations 2013 (as retained and amended post-Brexit, implementing the retained EU Regulation 1223/2009 as amended by Schedule 34 of the Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019). Before placing the product on the GB market, the RP must submit a Cosmetic Product Notification via the OPSS Submit Cosmetic Product Notification (SCPN) system operated by the Office for Product Safety and Standards (OPSS). Notification is required for each distinct cosmetic product. Northern Ireland follows EU rules (CPNP) under the Windsor Framework.The Cosmetic Products Enforcement Regulations 2013 (SI 2013/1478, as amended)
Retained EU Regulation (EC) No 1223/2009 on cosmetic products (as amended in UK law)
Product Safety and Metrology etc. (Amendment etc.) (EU Exit) Regulations 2019, Schedule 34
OPSS SCPN system (submit.cosmetic-product-notifications.service.gov.uk)		 Chinese NMPA registration or filing does NOT satisfy the UK SCPN notification requirement. A UK Responsible Person established in Great Britain must be appointed — a Chinese manufacturer cannot self-serve as RP from China. The UK SCPN portal (OPSS) is a separate system from the EU CPNP; existing EU CPNP notifications are not valid for GB market placement post-Brexit. Exporters must: (1) appoint a UK-established RP (importer, distributor, or specialist RP service), (2) complete SCPN for each product before GB market placement. Note: Northern Ireland RP/CPNP rules differ — flag if selling into NI.[INFORMATIONAL] Appointment of a UK Responsible Person and SCPN notification via the OPSS portal are mandatory before placing any cosmetic product on the GB market. Chinese NMPA authorisation does not substitute. EU CPNP notifications are not valid in GB post-Brexit. This is typically the first compliance step for any China-to-UK cosmetics export. UK Office for Product Safety and Standards (OPSS), GOV.UK2026-06-12 · unverified
Prohibited & Restricted Substances (UK Schedules — post-Brexit divergence) China's NMPA maintains equivalent substance lists under the CSAR 2021 framework: the '化妆品禁用原料目录' (Prohibited Ingredients List), '化妆品限用原料目录' (Restricted Ingredients List), '化妆品准用防腐剂目录' (Permitted Preservatives), '化妆品准用防晒剂目录' (Permitted UV Filters), '化妆品准用着色剂目录' (Permitted Colorants), and '化妆品准用染发剂目录' (Permitted Hair Dyes). These lists are maintained and updated by NMPA independently of the EU or UK schedules. There are known substance divergences — some substances permitted in China are restricted or banned in the UK/EU, and vice versa. A formulation compliant with NMPA lists is not automatically compliant with UK schedules.化妆品监督管理条例 (CSAR 2021)
化妆品禁用原料目录 (NMPA Prohibited Ingredients List, current edition)
化妆品限用原料目录 (NMPA Restricted Ingredients List, current edition)
化妆品准用防腐剂/防晒剂/着色剂/染发剂目录 (NMPA Permitted Lists, current editions)		 The retained Regulation (EC) 1223/2009 (as amended in UK law) contains Schedules (equivalent to Annexes II–VI of the original EU Regulation) listing: prohibited substances (Schedule 2 / Annex II), restricted substances (Schedule 3 / Annex III), permitted colorants (Schedule 4 / Annex IV), permitted preservatives (Schedule 5 / Annex V), and permitted UV filters (Schedule 6 / Annex VI). Since Brexit, the UK has maintained and updated these schedules independently of the EU. As of 2024–2026, notable UK-EU divergences have emerged, including: (a) UK has not adopted some EU SCCS opinion-driven bans (e.g., certain fragrance allergens listed under EU Regulation 2023/1545 updating Annex III); (b) UK maintains its own consultative process via the Scientific Advisory Group on Chemical Safety of Non-Food Consumer Products (CSCNCP); (c) some CMR (carcinogenic, mutagenic, reprotoxic) substance restrictions may differ. Exporters must check the current UK schedule against their formulation — the EU Annexes alone are no longer sufficient for UK compliance.Retained Regulation (EC) No 1223/2009, Schedules (Annexes) II–VI (as amended in UK law)
Cosmetic Products (Safety) Regulations 2004 (partially retained framework)
UK OPSS: Updates to the UK cosmetics regulation schedules (GOV.UK guidance page)		 Exporters must perform a formulation screen against the current UK Schedules (II–VI), not just the EU Annexes or Chinese NMPA lists. Post-Brexit divergences are growing — the UK and EU are updating their lists on independent timelines. Known risk areas include: (1) fragrance allergens (EU has extended mandatory declaration and restriction lists since Brexit — UK position may differ; verify current UK schedule); (2) certain preservatives (e.g., methylisothiazolinone restrictions); (3) CMR substances (UK applies retained REACH CMR provisions, which may diverge from EU updates post-Brexit); (4) nanomaterials (UK has its own notification and labelling rules). A Chinese manufacturer should have their UK RP conduct a gap analysis of the formulation against current UK schedules before SCPN submission.[INFORMATIONAL] UK substance schedules (Annexes II–VI of the retained regulation) are mandatory and diverging from EU Annexes post-Brexit. Chinese NMPA permitted/prohibited lists are not equivalent. A dedicated formulation gap analysis against current UK schedules is required for every product. Post-Brexit divergences in fragrance allergens, preservatives, and CMR substances represent the highest-risk areas for Chinese exporters. legislation.gov.uk (retained Regulation (EC) 1223/2009 with UK amendments)2026-06-12 · unverified

E-E-A-T

Named editorial review

Pending named reviewer

Official regulator, standards body, notified body, customs, or primary legal source preferred. Local PDFs are not accepted.

Editorial controls

Rows must include publisher, official URL, access date, verification flag, and last_verified before human_reviewed can be true.

SOURCES

Official-source register.